Christopher Park
Associate Professor and Director of Pathology Education and Translational Research at NYU Langone Medical Center, focused on blood cancers and leukemia stem cells and author of a recent Science Translational Medicine publication discussed in this episode.
Best podcasts with Christopher Park
Ranked by the Snipd community
Feb 14, 2017 • 1h 13min
Ep. 85: “Killer Antibodies” Featuring Dr. Christopher Park
Dr. Christopher Park, Associate Professor at NYU Langone who studies blood cancers and leukemia stem cells. He talks about identifying CD99 as a marker on malignant stem-like cells. He explains how an anti-CD99 antibody can directly kill leukemic cells and ideas to pair it with mobilization or monitoring strategies. The conversation covers diagnostics like flow cytometry and prospects for preventative and transplant-related therapies.
